Obesity & Diabetes Clinical Trials
Run across 20 of our 30+ research sites, on one operating model and one quality system.
Request feasibilityProven metabolic disease expertise, and trials enrolling today.
DM Clinical Research is a recognized leader in metabolic disease clinical trials, having successfully conducted 120+ obesity & diabetes studies across our national network since 2006. Our obesity & diabetes program spans type 2 diabetes, obesity, prediabetes, nash / mash, metabolic syndrome, and high cholesterol, backed by a 1.97M+ patient database, bilingual recruitment, and the operational rigor behind a clean inspection record.
For sponsors, that means real patient access and shortlist-ready feasibility in a high-demand area. For patients, it means access to investigational metabolic disease treatments at no cost, with study care and compensation for time and travel.
Sites running obesity & diabetes studies.
Boston
View site details and contact →
Brooklyn
View site details and contact →
Chicago
View site details and contact →
Dallas Irving
View site details and contact →
Detroit
View site details and contact →
Houston
View site details and contact →
Indianapolis
View site details and contact →
Jersey City
View site details and contact →
Miami
View site details and contact →
Philadelphia
View site details and contact →
Phoenix
View site details and contact →
San Antonio
View site details and contact →
Seattle
View site details and contact →
Tomball
View site details and contact →
Bradenton
View site details and contact →
Dallas
View site details and contact →
Sugar Land
View site details and contact →
Trident Peoria
View site details and contact →
Phoenix 2nd Street
View site details and contact →
Tomball Medical Complex
View site details and contact →
See if you qualify.
Answer a few short questions and our enrollment team will be in touch. Studies are at no cost to you, and you are compensated for your time.
Trouble with the form? Open it in a new tab, or call (281) 517-0550.
Advance your programme with DM.
Send the protocol synopsis and we will come back with site-level feasibility and real patient counts.
Contact business development